Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The development of standardized case definitions and guidelines for adverse events following immunization.
Kohl KS, Gidudu J, Bonhoeffer J, Braun MM, Buettcher M, Chen RT, Drammeh B, Duclos P, Heijbel H, Heininger U, Hummelman E, Jefferson T, Keller-Stanislawski B, Loupi E, Marcy SM. Kohl KS, et al. Among authors: loupi e. Vaccine. 2007 Aug 1;25(31):5671-4. doi: 10.1016/j.vaccine.2007.02.063. Epub 2007 Mar 12. Vaccine. 2007. PMID: 17400339 No abstract available.
The Brighton Collaboration-enhancing vaccine safety.
Bonhoeffer J, Kohl K, Chen R, Duclos P, Heijbel H, Heininger U, Jefferson T, Loupi E; Brighton Collaboration. Bonhoeffer J, et al. Among authors: loupi e. Vaccine. 2004 May 7;22(15-16):2046. doi: 10.1016/j.vaccine.2004.01.016. Vaccine. 2004. PMID: 15121320 No abstract available.
The Brighton Collaboration: enhancing comparability of vaccine safety data.
Kohl KS, Bonhoeffer J, Chen R, Duclos P, Heijbel H, Heininger U, Loupi E. Kohl KS, et al. Among authors: loupi e. Pharmacoepidemiol Drug Saf. 2003 Jun;12(4):335-40. doi: 10.1002/pds.851. Pharmacoepidemiol Drug Saf. 2003. PMID: 12812014 Review. No abstract available.
Causality assessment revisited in reply to Meyboom R.H.B.
Loupi E. Loupi E. Pharmacoepidemiol Drug Saf. 1999 Aug;8(5):353. doi: 10.1002/(SICI)1099-1557(199908/09)8:5<353::AID-PDS433>3.0.CO;2-H. Pharmacoepidemiol Drug Saf. 1999. PMID: 15073913 No abstract available.
Which pharmacovigilance for vaccines?
Le Louët H, Loupi E, Haramburu F; Round Table No 3, Giens XXII. Le Louët H, et al. Among authors: loupi e. Therapie. 2007 May-Jun;62(3):241-7. doi: 10.2515/therapie:2007039. Epub 2007 Sep 6. Therapie. 2007. PMID: 17803893 Free article. Review. English, French.
Which Pharmacovigilance for Vaccines?
Le Louët H, Loupi E, Haramburu F; participants in Round Table N° 3, Giens XXII. Le Louët H, et al. Among authors: loupi e. Therapie. 2007 May-Jun;62(3):245-7. doi: 10.2515/therapie:2007039. Therapie. 2007. PMID: 27393410
Quelle pharmacovigilance pour les vaccins ?
Le Louët H, Loupi E, Haramburu F; participants de la table ronde n°3 de Giens XXII. Le Louët H, et al. Among authors: loupi e. Therapie. 2007 May-Jun;62(3):241-4. doi: 10.2515/therapie:2007048. Therapie. 2007. PMID: 27393409 French.
The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization.
Kohl KS, Bonhoeffer J, Braun MM, Chen RT, Duclos P, Heijbel H, Heininger U, Loupi E, Marcy SM; The Brighton Collaboration. Kohl KS, et al. Among authors: loupi e. In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb. In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb. PMID: 21249832 Free Books & Documents. Review.
34 results